Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

94
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
94
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

118
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
118
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

101
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
101
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

87
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
87
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

99
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
99
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

399
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
399

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender Pay Equity in Pediatrics: Policy Statement.

Pediatrics·2026
Same author

Extending the Mandatory Promotion Timeline: Career Outcomes Disaggregated by Gender.

Journal of women's health (2002)·2026
Same author

Effective Community Consultation for Prehospital EFIC Research: Lessons from a 20-Site Pediatric Trial.

Prehospital emergency care·2026
Same author

Association of EEG Response to Hypertonic Saline and Neurologic Outcomes in Pediatric Acute Brain Injury.

Neurocritical care·2026
Same author

Treatment Practices for Infantile Epileptic Spasms Syndrome: Consensus and Variation in Major Pediatric Epilepsy Centers.

Pediatric neurology·2025
Same author

Show Me the Money: A Movement Towards Transparency in Pediatric Emergency Medicine Compensation.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2025

Related Experiment Video

Updated: Nov 14, 2025

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
06:09

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine

Published on: January 12, 2024

853

Differences in Lifetime Earning Potential for Pediatric Subspecialists.

Eva Catenaccio1, Jonathan M Rochlin2, Harold K Simon3

  • 1Division of Pediatric Neurology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland; eva.catenaccio@gmail.com.

Pediatrics
|March 9, 2021
PubMed
Summary
This summary is machine-generated.

Pediatric fellowship training often results in significant financial loss compared to general pediatrics, with widening income gaps. Interventions like shorter training or loan repayment could improve financial outcomes for subspecialists.

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

698
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.1K

Related Experiment Videos

Last Updated: Nov 14, 2025

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
06:09

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine

Published on: January 12, 2024

853
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

698
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.1K

Area of Science:

  • Medical Economics
  • Pediatric Subspecialties
  • Physician Compensation

Background:

  • Previous analysis in 2011 indicated financial drawbacks of pediatric fellowship training.
  • This study updates the financial impact analysis using more recent data.

Purpose of the Study:

  • To analyze the financial returns of pediatric fellowship training versus general pediatrics.
  • To model interventions to improve the financial viability of pediatric subspecialties.

Main Methods:

  • Estimated financial returns for subspecialists vs. general pediatricians.
  • Modeled effects of debt elimination, shorter fellowships, and loan repayment programs.
  • Compared 2018-2019 financial data to 2007-2008 data.

Main Results:

  • Fellowship training yielded variable returns, from +$852,129 (cardiology) to -$1,594,366 (adolescent medicine).
  • Twelve of 15 subspecialties showed negative financial returns.
  • The financial gap between highest and lowest earners widened significantly between 2007-2008 and 2018-2019.

Conclusions:

  • Pediatric fellowship training presents a substantial financial challenge for many subspecialties.
  • Shortening training duration and implementing loan repayment programs can mitigate negative financial impacts.
  • Findings can guide trainees, educators, and policymakers to ensure a robust pediatric workforce.